Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, June, 2009, Advertising

New pharmaceutical account wins notified to us by the winning agency for the period April 2009 and June 2009 inclusive:

New pharmaceutical account wins notified to us by the winning agency for the period April 2009 and June 2009 inclusive:

       

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

Abbott Laboratories/ International
Kaletra
Virology
Grace Agency
ApaTech Actifuse Bone graft material Fleishman-Hillard International
Bausch & Lomb Ocuvite Ophthalmology (OTC)
Pulsar Healthcare Communications
Bausch & Lomb PreserVision Ophthalmology (OTC)
Pulsar Healthcare Communications
Baxter Healthcare Renal Division Home dialysis Renal
Life
Boehringer Ingelheim
New product launch
Women's Health
MSA Market Media
Bupa Home Healthcare N/A Corporate Pulsar Healthcare Communications
CarieScan CarieScan Dentistry Pulsar Healthcare Communications
Gilead
Early treatment project
HIV
Life
IS Pharma         Haemopressin/ Variquel (Europe) Hepatology Pulsar Healthcare Communications
Novo Nordisk
NovoSeven corporate
Haemophilia
Life
Reckitt Benckiser Nurofen Analgesia Hive
Spectrum Thea        Virgan Ophthalmology Pulsar Healthcare Communications
Teva Ireland Naramerg CNS Pulsar Healthcare Communications

  

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

7th July 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics